(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

Lyft Earnings Miss Estimates After Global Expansion Push
25:56

Wall Street Poised for Bonus Increases in ‘Year of the Bank’
26:24

AMD Soars as AI Demand Fuels Better-Than-Expected Sales Outlook
20:33